InvestSMART

ReNerve Limited (ASX: RNV) - Announcements

Current share price for RNV : $0.076 0.005 (6.17%)+

ASX company news and announcements for ReNerve Limited (RNV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ReNerve Limited (RNV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ReNerve Limited (RNV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ReNerve Limited (RNV)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$11 Notification of cessation of securities - RNV 16 Jun 2026 9:02AM $0.084 $0.076 fallen by 9.52%
$11 Clarification of Key Terms STC Distribution Agreement 16 Jun 2026 9:01AM $0.084 $0.076 fallen by 9.52%
$11 ReNerve appoints J4 as second Empliq manufacturing partner 11 Jun 2026 9:47AM $0.077 $0.076 fallen by 1.30%
$11 ReNerve appoints distribution partner for Malaysian Market 5 Jun 2026 9:15AM $0.077 $0.076 fallen by 1.30%
$11 New distribution agreement for broader Hong Kong market 1 Jun 2026 9:44AM $0.080 $0.076 fallen by 5%
$11 Quarterly Investor Presentation 8 May 2026 10:02AM $0.088 $0.076 fallen by 13.64%
$11 Quarterly Investor Webinar 1 May 2026 11:00AM $0.105 $0.076 fallen by 27.62%
$11 Notification of cessation of securities - RNV 1 May 2026 9:11AM $0.105 $0.076 fallen by 27.62%
$11 Final Director's Interest Notice - D Rhodes 30 Apr 2026 9:53AM $0.110 $0.076 fallen by 30.91%
$11 Q3 FY26 Activities Report and Appendix 4C 30 Apr 2026 9:50AM $0.110 $0.076 fallen by 30.91%
$11 Nerve Guide Matrix Enters Stage 3 of Commercial Development 15 Apr 2026 9:45AM $0.100 $0.076 fallen by 24%
$11 Notification of cessation of securities - RNV 31 Mar 2026 9:31AM $0.095 $0.076 fallen by 20%
$11 Cleansing Notice 24 Mar 2026 11:47AM $0.097 $0.076 fallen by 21.65%
$11 Application for quotation of securities - RNV 24 Mar 2026 11:46AM $0.097 $0.076 fallen by 21.65%
$11 Proposed issue of securities - RNV 24 Mar 2026 8:47AM $0.097 $0.076 fallen by 21.65%
$11 Half Year Investor Presentation 17 Mar 2026 10:38AM $0.105 $0.076 fallen by 27.62%
$11 Half Year Investor Webinar 10 Mar 2026 8:42AM $0.098 $0.076 fallen by 22.45%
$11 1HFY26 Results Announcement 26 Feb 2026 10:49AM $0.110 $0.076 fallen by 30.91%
$11 1HFY26 Appendix 4D and Half Year Report 26 Feb 2026 10:48AM $0.110 $0.076 fallen by 30.91%
$11 Cleansing notice 18 Feb 2026 8:17AM $0.115 $0.076 fallen by 33.91%
$11 Application for quotation of securities - RNV 18 Feb 2026 8:17AM $0.115 $0.076 fallen by 33.91%
$11 Proposed issue of securities - RNV 17 Feb 2026 9:48AM $0.115 $0.076 fallen by 33.91%
$11 ReNerve Receives $517k R&D Refund 16 Feb 2026 9:33AM $0.120 $0.076 fallen by 36.67%
$11 Q2 FY26 Activities Report and Appendix 4C 30 Jan 2026 10:27AM $0.100 $0.076 fallen by 24%
$11 ReNerve receives approval in Malaysia 15 Jan 2026 9:17AM $0.100 $0.076 fallen by 24%

1 - 25 of 140 results

Page 1 of 6

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.